SyntheX Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Employees
  • 11
Employees
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $4M
Latest Deal Amount
  • Investors
  • 9

SyntheX General Information

Description

Developer of a novel cell-based, synthetic biology-driven drug selection platform designed to provide efficient synthesis and identification of peptides and macrocycles. The company's platform discovers and designs drugs that target specific previously undruggable targets for therapeutic and biotechnological applications, enabling healthcare institutions to better serve human health for the treatment of cancer and rare diseases.

Contact Information

Website
www.synthexlabs.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 409 Illinois Street
  • San Francisco, CA 94158
  • United States
+1 (415) 000-0000

SyntheX Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SyntheX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Early Stage VC 03-Sep-2020 $4M 000.00 Completed Pre-Clinical Trials
6. Debt - PPP 27-Apr-2020 00.00 Completed Pre-Clinical Trials
5. Accelerator/Incubator 03-Jul-2018 00.00 Completed Pre-Clinical Trials
4. Seed Round 27-Apr-2017 00.000 00.00 000.00 Completed Pre-Clinical Trials
3. Accelerator/Incubator 27-Apr-2017 00000 Completed Pre-Clinical Trials
2. Accelerator/Incubator 01-Mar-2016 $350K $350K Completed Product In Beta Test
1. Accelerator/Incubator 01-Jan-2016 Completed Product In Beta Test
To view SyntheX’s complete valuation and funding history, request access »

SyntheX Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view SyntheX’s complete cap table history, request access »

SyntheX Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a novel cell-based, synthetic biology-driven drug selection platform designed to provide efficient synthesi
Biotechnology
San Francisco, CA
11 As of 2020
000.00
0000000000 0 000.00

00000000

ris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate vel
0000 000000000
San Diego, CA
00 As of 0000
00000
00000000000 00000

000000 0

, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut
0000000000000
Watertown, MA
00 As of 0000
00000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SyntheX Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vividion Therapeutics Venture Capital-Backed San Diego, CA 00 00000 00000000000 00000
000000 00000000000 Formerly VC-backed Watertown, MA 00 00000 00000000 00000
0000000 Venture Capital-Backed San Diego, CA 00 0000 00000 00000 0000
000000 000000 Venture Capital-Backed South San Francisco, CA 00 000.00 00000000000 000.00
0000000 0000000000 Formerly VC-backed Cambridge, United Kingdom 00 00000 000000000 00000
You’re viewing 5 of 13 competitors. Get the full list »

SyntheX Executive Team (3)

Name Title Board Seat Contact Info
Maria Soloveychik Ph.D Co-Founder, Chief Executive Officer & Board Member
Charly Chahwan Co-Founder, Chief Scientific Officer & Board Member
Tri Luong Head of Finance & Operations
To view SyntheX’s complete executive team members history, request access »

SyntheX Board Members (3)

Name Representing Role Since
Arvind Gupta SOSV Board Member 000 0000
Charly Chahwan SyntheX Co-Founder, Chief Scientific Officer & Board Member 000 0000
Maria Soloveychik Ph.D SyntheX Co-Founder, Chief Executive Officer & Board Member 000 0000
To view SyntheX’s complete board members history, request access »

SyntheX Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SyntheX Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
OMX Ventures Venture Capital Minority 000 0000 000000 0
MBC BioLabs Accelerator/Incubator 000 0000 000000 0
8VC Venture Capital Minority 000 0000 000000 0
JLABS Accelerator/Incubator 000 0000 000000 0
Morgan Noble Healthcare Partners PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial